1. |
Dei Tos AP, Pedeutour F. Atypical lipomatous tumour. //Fletcher CDM, Bridge JA, Hogendoorn PCW, et al. eds. WHO Classification of Tumours of Soft Tissue and Bone. fourth ed. Lyon, France: IARC; 2013: 33-36.
|
2. |
Lucas DR, Nascimento AG, Sanjay BK, et al. Well-differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Surg Pathol, 1994, 102(5): 677-683.
|
3. |
Laurino L, Furlanetto A, Orvieto E, et al. Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol, 2001, 18(4): 258-262.
|
4. |
潘丹玲, 陈小岩, 陈灵锋, 等. 非典型性脂肪瘤性肿瘤/高分化脂肪肉瘤 MDM2 蛋白表达和基因扩增检测及临床意义. 临床与实验病理学杂志, 2017, 33(7): 759-762.
|
5. |
彭燕, 邢晓皖, 翁海燕, 等. 非典型性脂肪瘤性肿瘤/分化良好的脂肪肉瘤的临床病理分析. 现代肿瘤医学, 2012, 20(11): 2401-2404.
|
6. |
周睿, 王鲁平, 李静. 纵隔非典型性脂肪瘤性肿瘤/高分化脂肪肉瘤临床病理学分析. 诊断病理学杂志, 2007, 14(3): 190-193, 201.
|
7. |
刘飞飞, 张仁亚. 非典型性脂肪瘤性肿瘤及各种变型和复合形式. 临床与实验病理学杂志, 2007, 1: 105.
|
8. |
宋创业, 尚培中, 吕振海, 等. 四肢非典型性脂肪瘤性肿瘤/高分化脂肪肉瘤误诊为淋巴管瘤 1 例. 河北北方学院学报 (自然科学版), 2015, 31(5): 104, 111.
|
9. |
聂明豪, 李秀荣, 佟喜芹. 睾丸旁非典型性脂肪瘤性肿瘤 1 例. 临床与实验病理学杂志, 2009, 25(3): 342.
|
10. |
Michal M, Agaimy A, Contreras AL, et al. Dysplastic lipoma: a distinctive atypical lipomatous neoplasm with anisocytosis, focal nuclear atypia, p53 overexpression, and a lack of MDM2 gene amplification by FISH; a report of 66 cases demonstrating occasional multifocality and a rare association with retinoblastoma. Am J Surg Pathol, 2018, 42(11): 1530-1540.
|
11. |
Agaimy A. Anisometric cell lipoma: insight from a case series and review of the literature on adipocytic neoplasms in survivors of retinoblastoma suggest a role for RB1 loss and possible relationship to fat-predominant ("fat-only") spindle cell lipoma. Ann Diagn Pathol, 2017, 29: 52-56.
|
12. |
Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol, 2009, 27(1): 24-30.
|
13. |
Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol, 2009, 27(1): 31-37.
|
14. |
Italiano A, Bianchini L, Keslair F, et al. HMGA2 is the partner of MDM2 in welldifferentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer, 2008, 122(10): 2233-2241.
|